Logo image of UMI.BR

UMICORE (UMI.BR) Stock Fundamental Analysis

EBR:UMI - Euronext Brussels - BE0974320526 - Common Stock - Currency: EUR

14.77  +0.55 (+3.87%)

Fundamental Rating

3

Overall UMI gets a fundamental rating of 3 out of 10. We evaluated UMI against 68 industry peers in the Chemicals industry. UMI may be in some trouble as it scores bad on both profitability and health. UMI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

UMI had positive earnings in the past year.
In the past year UMI had a positive cash flow from operations.
Of the past 5 years UMI 4 years were profitable.
In the past 5 years UMI always reported a positive cash flow from operatings.
UMI.BR Yearly Net Income VS EBIT VS OCF VS FCFUMI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

The Return On Assets of UMI (-15.72%) is worse than 82.35% of its industry peers.
With a Return On Equity value of -76.36%, UMI is not doing good in the industry: 86.76% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -15.72%
ROE -76.36%
ROIC N/A
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
UMI.BR Yearly ROA, ROE, ROICUMI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

UMI's Gross Margin of 8.17% is on the low side compared to the rest of the industry. UMI is outperformed by 83.82% of its industry peers.
UMI's Gross Margin has improved in the last couple of years.
UMI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
UMI.BR Yearly Profit, Operating, Gross MarginsUMI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1

2. Health

2.1 Basic Checks

UMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UMI has about the same amount of shares outstanding.
The number of shares outstanding for UMI remains at a similar level compared to 5 years ago.
UMI has a worse debt/assets ratio than last year.
UMI.BR Yearly Shares OutstandingUMI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
UMI.BR Yearly Total Debt VS Total AssetsUMI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 1.73, we must say that UMI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.73, UMI is doing worse than 69.12% of the companies in the same industry.
UMI has a debt to FCF ratio of 12.00. This is a negative value and a sign of low solvency as UMI would need 12.00 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.00, UMI is in line with its industry, outperforming 57.35% of the companies in the same industry.
A Debt/Equity ratio of 1.49 is on the high side and indicates that UMI has dependencies on debt financing.
UMI has a worse Debt to Equity ratio (1.49) than 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 12
Altman-Z 1.73
ROIC/WACCN/A
WACC5.97%
UMI.BR Yearly LT Debt VS Equity VS FCFUMI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.28 indicates that UMI should not have too much problems paying its short term obligations.
UMI's Current ratio of 1.28 is on the low side compared to the rest of the industry. UMI is outperformed by 75.00% of its industry peers.
A Quick Ratio of 0.77 indicates that UMI may have some problems paying its short term obligations.
The Quick ratio of UMI (0.77) is worse than 79.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.77
UMI.BR Yearly Current Assets VS Current LiabilitesUMI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

UMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.01%.
The Earnings Per Share has been decreasing by -3.85% on average over the past years.
The Revenue for UMI has decreased by -18.68% in the past year. This is quite bad
The Revenue has been decreasing by -3.21% on average over the past years.
EPS 1Y (TTM)-43.01%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%-35.96%
Revenue 1Y (TTM)-18.68%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-8.4%

3.2 Future

Based on estimates for the next years, UMI will show a small growth in Earnings Per Share. The EPS will grow by 7.13% on average per year.
Based on estimates for the next years, UMI will show a small growth in Revenue. The Revenue will grow by 1.83% on average per year.
EPS Next Y-3.54%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
EPS Next 5Y7.13%
Revenue Next Year-5.32%
Revenue Next 2Y-0.3%
Revenue Next 3Y-0.2%
Revenue Next 5Y1.83%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UMI.BR Yearly Revenue VS EstimatesUMI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
UMI.BR Yearly EPS VS EstimatesUMI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.93 indicates a correct valuation of UMI.
Based on the Price/Earnings ratio, UMI is valued cheaper than 83.82% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, UMI is valued a bit cheaper.
A Price/Forward Earnings ratio of 14.45 indicates a correct valuation of UMI.
UMI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. UMI is cheaper than 64.71% of the companies in the same industry.
UMI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 13.93
Fwd PE 14.45
UMI.BR Price Earnings VS Forward Price EarningsUMI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, UMI is valued cheaper than 80.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.7
EV/EBITDA N/A
UMI.BR Per share dataUMI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.94%
EPS Next 3Y3.83%

4

5. Dividend

5.1 Amount

UMI has a Yearly Dividend Yield of 2.43%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.08, UMI pays a bit more dividend than its industry peers.
UMI's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.43%

5.2 History

The dividend of UMI has a limited annual growth rate of 0.67%.
Dividend Growth(5Y)0.67%
Div Incr Years0
Div Non Decr Years4
UMI.BR Yearly Dividends per shareUMI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

The earnings of UMI are negative and hence is the payout ratio. UMI will probably not be able to sustain this dividend level.
UMI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-13%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
UMI.BR Yearly Income VS Free CF VS DividendUMI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

UMICORE

EBR:UMI (7/11/2025, 7:00:00 PM)

14.77

+0.55 (+3.87%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-14 2025-02-14/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners38.34%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.64B
Analysts65.71
Price Target11.89 (-19.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.43%
Yearly Dividend0.8
Dividend Growth(5Y)0.67%
DP-13%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.46%
PT rev (3m)0.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-26.45%
Valuation
Industry RankSector Rank
PE 13.93
Fwd PE 14.45
P/S 0.25
P/FCF 12.7
P/OCF 4.19
P/B 1.88
P/tB 2.35
EV/EBITDA N/A
EPS(TTM)1.06
EY7.18%
EPS(NY)1.02
Fwd EY6.92%
FCF(TTM)1.16
FCFY7.87%
OCF(TTM)3.53
OCFY23.87%
SpS60.28
BVpS7.87
TBVpS6.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.72%
ROE -76.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.17%
FCFM 1.93%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
F-Score2
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 12
Debt/EBITDA N/A
Cap/Depr 204.16%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 0.77
Altman-Z 1.73
F-Score2
WACC5.97%
ROIC/WACCN/A
Cap/Depr(3y)224.12%
Cap/Depr(5y)196.78%
Cap/Sales(3y)3.57%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.01%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%-35.96%
EPS Next Y-3.54%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
EPS Next 5Y7.13%
Revenue 1Y (TTM)-18.68%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-8.4%
Revenue Next Year-5.32%
Revenue Next 2Y-0.3%
Revenue Next 3Y-0.2%
Revenue Next 5Y1.83%
EBIT growth 1Y-313.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.35%
EBIT Next 3Y19.67%
EBIT Next 5Y15.5%
FCF growth 1Y81.43%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-16.68%
OCF growth 3Y-11.62%
OCF growth 5Y12.64%